Blockchain Registration Transaction Record
American Heart Association Initiative Targets Access to Gene Editing Therapies for Cardiomyopathy
American Heart Association launches initiative to improve access to gene editing therapies for transthyretin amyloid cardiomyopathy (ATTR-CM) in underserved populations. Learn how this program aims to enhance patient care and outcomes for a specific heart condition.
This news matters as it highlights efforts to address healthcare disparities by providing access to cutting-edge therapies for a specific heart condition in underserved communities. By focusing on education, outreach, and clinical trial support, the initiative aims to improve outcomes for individuals with ATTR-CM, ultimately advancing cardiovascular care for all populations.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0x4ee09828f9acccadf31d55b8d8fcae8501221d4c16eee0cbd687903284c01f91 |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | taroL6_X-f066f8597874b368bfba38bbb69c834d |